Each year in late spring our Pilot & Feasibility Program issues a call for proposals. Following review by external experts, three outstanding projects were chosen for funding:
1. Charles Harris, M.D., Ph.D.
“GR post-translational modification in adipogenesis and adipocyte function”
2. Jason Held, Ph.D.
“Thiolproteomic characterization of in vivo cysteine redox sensors in diabetes”
3. Joel Schilling, M.D., Ph.D.
“Macrophage PPAR gamma as a regulator of ischemic cardiac remodeling”